6201 Penn Therapeutics CRS — Philadelphia, Pennsylvania

6201 Penn Therapeutics CRS is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Clinical Trials Trust Score: 15/100 (FAILING). This profile has not yet been claimed by the site owner.

6201 Penn Therapeutics CRS has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Acute HIV Infection, HIV-1 Infection, Hepatitis.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID), Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

• Jefferson University Physicians (JUP) - Jefferson Pulmonary
• Perelman Center for Advanced Medicine at the Hospital of the University of Pennsylvania
• Thomas Jefferson University Hospital /ID# 232614
• Thomas Jefferson University Hospital;Medical Oncology
• Thomas Jefferson Memorial Hospital
• Fox Chase Temple Cancer Center - Temple University
• University of Pennsylania, Perelman School of Medicine
• Thomas Jefferson University_Philadelphia
• Thomas Jefferson University Hospital, Cardiovascular Associates
• Thomas Jefferson University Honickman Center
• Sidney Kimmel Comprehensive Cancer Center - Thomas Jefferson University Hospital
• Presbyterian Hospital, Department of Medicine, University of Pennsylvania Perelman School of Medicine

Sponsor Feasibility Report

Trust Score: 15/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 6201 Penn Therapeutics CRS?

6201 Penn Therapeutics CRS has a Crixeo Trust Score of 15/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 6201 Penn Therapeutics CRS conducted?

6201 Penn Therapeutics CRS has 5 clinical trials on record, with 2 currently active. Their work covers Acute HIV Infection, HIV-1 Infection, Hepatitis.

Is 6201 Penn Therapeutics CRS accredited by Crixeo Clinical Trials?

6201 Penn Therapeutics CRS has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 6201 Penn Therapeutics CRS?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.